% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • jksnnh jksnnh Feb 26, 2013 8:00 PM Flag

    buy now-stock will at least double one year from now

    Based on the data tonight, the Phase 3 trial 600mg QD arm will be statistically and clinically relevant when all is said and done. treating 15,000 CF patients at $300k per year is $4.5B in unencumbered revenue in my book. Once VRTX emerges as an "orphan" company with that revenue stream and finally afforded an orphan premium (5-10x revenues), we are looking at a $25-30B market cap company easily. between now and then the street will slowly catch up to this realization and take vertex out of this hep c dominated penalty box of a valuation they currently sit in.

75.84-2.87(-3.65%)4:00 PMEDT